-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Moderna to Present at Upcoming Conference in November 2026
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
SNZweig Forms AEC Industry Advisory Council
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Medical Care Technologies Inc. (OTCID:MDCE) Subsidiaries to Manage $20 Million in Private Collectibles Assets
-
Opportunistic Trader ETF(WZRD) to Delist and Liquidate
-
LiveOne (Nasdaq: LVO) Releases Preliminary H1 Fiscal 2027 Results: $37.3 Million in Revenue and Record Audio Adjusted EBITDA* of $7.8 Million, Up 619% Year-Over-Year
-
Critics and Listeners Agree: Eylsia Nicolas' "The Wedding Song" Nominated for GlacerFM's Best Pop Song 2026; Second Consecutive Listener's Choice Nomination Follows Widespread Critical Recognition and Growing Global Audience
-
GoodData.AI Launches the Agentic Serving Plane, a New Category of Enterprise Data Infrastructure for AI Agents
-
Guard Home Warranty Launches Claims 2.0: A Real US-Based Person in 16 Seconds, Claims Reimbursed Instantly
-
Envision Pharma Group appoints Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian
The Silent Trailblazer: Dr. Azriel Hirschfeld, Oncology's Best-Kept Secret
Unveiling Dr. Hirschfeld: The Oncologist Who Defies Odds and Inspires Hope
BROOKLYN, NY / ACCESS Newswire / May 1, 2025 / In the world of oncology, where each diagnosis can feel like a looming shadow, there exists a beacon of hope-a physician who dares to venture beyond the constraints of conventional medicine, offering patients not just treatment but a fighting chance. Dr. Azriel Hirschfeld, once a well-kept secret in the medical community, is now emerging as a pivotal figure in the battle against one of the most feared diseases. His story is one of unparalleled expertise, innovative treatment approaches, and a deep-seated commitment to patient care.
Innovative Approaches to Cancer Treatment
Dr. Hirschfeld's journey in medicine began at the Albert Einstein College of Medicine, followed by a residency in Internal Medicine at Temple University Hospital. He then completed a fellowship in Hematology and Oncology at the University of Maryland Medical Center's Greenebaum Cancer Center. This comprehensive education laid the foundation for his innovative approach to cancer treatment.
What sets Dr. Hirschfeld apart in the field of oncology is his unwavering commitment to exploring every possible avenue of treatment. His methods encompass a wide range of therapies, including immunotherapy, targeted therapy, and low-dose combination chemotherapy. Each treatment plan is meticulously tailored to the specific profile of both the cancer and the patient, ensuring the most effective and personalized care.
One of Dr. Hirschfeld's groundbreaking methods includes the strategic use of low-dose combination chemotherapy. This involves using multiple chemotherapy drugs-sometimes 4-6-at lower doses, which allows for safer combinations with better toxicity profiles. This method harnesses the synergistic interactions of multiple drugs, making it a powerful and effective approach for treating even the most resistant cancers. Dr. Hirschfeld has seen remarkable results with this approach, offering new hope to many patients.
Ruby's Battle with Intrahepatic Cholangiocarcinoma
Ruby's journey began with a diagnosis that would leave most in despair: intrahepatic cholangiocarcinoma, a rare and aggressive form of bile duct cancer. A rapid decline in her health led to a shocking prognosis-six months to live. But Ruby refused to give up. Her search for a second opinion brought her to Dr. Hirschfeld, a meeting she describes as transformative.
Unlike larger institutions bound by rigid protocols, Dr. Hirschfeld offered a personalized approach, tailoring her treatment to her unique health needs. The combination of chemotherapy and immunotherapy under his care yielded improvements that defied the odds. Ruby, who was once told her time was limited, now approaches each day with hope, a testament to Dr. Hirschfeld's innovative and compassionate care.
Sarah's Struggle with Stage 4 Colon Cancer
Sarah's story is one of resilience against recurring stage 4 colon cancer, a battle that began in 2015. Despite aggressive treatments at a top hospital, including multiple surgeries and rounds of chemotherapy, the cancer returned with a vengeance. It seemed as though hope was slipping away-until Sarah and her husband found Dr. Hirschfeld.
What set Dr. Hirschfeld apart was his willingness to step outside the box. At a time when other doctors were constrained by protocol, Dr. Hirschfeld's approach was both scientific and creative. He wasn't just treating cancer; he was battling it with every tool at his disposal. Sarah's markers, once ominously high, began to decrease under his care. The turning point came when a CT scan revealed that much of the cancer had disappeared-a result that astonished even the radiologist.
Sarah's husband reflects on their journey with Dr. Hirschfeld: "Cancer is a horrible disease, but with Dr. Hirschfeld, we finally had hope. He pushes the boundaries of what's possible, always staying up-to-date with the latest developments in oncology. His vast knowledge and dedication are unparalleled."
A Doctor Who Cares
In a field where the emotional toll can be as heavy as the physical, Dr. Hirschfeld stands out as a physician who deeply cares about his patients. He takes the time to listen, to understand, and to adapt his treatments to the ever-changing landscape of each patient's condition. His patients are not just case numbers; they are individuals whose lives he is committed to saving.
Sarah's spouse recalls the contrast between their previous treatment experience and their time with Dr. Hirschfeld: "We were coming from this really top hospital with every amenity you could imagine. Now, the result, people were saying, 'Go to Dr. Hirschfeld.' We pulled up in front of this building, and we came into this office that certainly didn't have the fine, tasteful leather and mahogany that we were used to from Manhattan."
Despite the modest surroundings, Sarah and her spouse knew instantly that they were in the right place. "There was no question right away that this was someone who we were going to entrust Sarah's future with because she wasn't giving up hope."
This blend of expertise and empathy is what has led to remarkable outcomes for patients like Sarah, whose markers-a key indicator in cancer treatment-dropped significantly under Dr. Hirschfeld's care. The results of the CAT scan were nothing short of extraordinary. "When we sat down by Dr. Hirschfeld, he had just received a phone call from the radiologist. Although normally the radiologist just waits till he issues the report a few days later, he felt that he had to tell Dr. Hirschfeld that there was an amazing change and a lot of the cancer had disappeared."
Dr. Hirschfeld, known for his dedication to his patients, was so moved by the news that he became choked up while delivering it to Sarah and her spouse. "He was starting to try to tell us, but he got choked up. It took him a few seconds to compose himself, and then he told us the amazing news that there was a real, real recession of the spread and it was in a lot fewer areas. It was still there and it was still a fight to fight, but we were making progress."
A Legacy of Compassion and Innovation
At the forefront of cancer treatment, Dr. Hirschfeld's practice considers every medical advancement, ensuring that each patient receives a personalized approach. His refusal to be bound by limitations drives him to push the boundaries of what's possible in oncology, transforming every challenge into an opportunity for groundbreaking care.
As Ruby and Sarah's stories illustrate, Dr. Hirschfeld's impact goes far beyond the walls of his practice. He is a doctor who not only fights cancer but also empowers his patients to reclaim their lives, one day at a time.
For families seeking 24/7 answers and support, Dr. Hirschfeld offers a unique resource on his website in partnership with one of the leading medical digital strategists, DAS Consultants with their AI Chat. As the only oncologist to leverage this technology, Dr. Hirschfeld ensures that patients receive answers to their queries at the moment they seek them.
Dr. Hirschfeld may have been a well-kept secret, but as his story unfolds, it's clear that he is a lifeline in the battle against cancer-a doctor whose compassion and expertise are changing lives, one patient at a time.
To learn more about Dr. Hirschfeld and how he's changing lives, visit honcology.com, email the office at [email protected], or call 718-732-4050.
CONTACT: Karla Witkowski
[email protected]
718-732-4050
SOURCE: Hirschfeld Oncology
View the original press release on ACCESS Newswire
X.Karnes--AMWN